Current Hematologic Malignancy Reports

Papers
(The H4-Index of Current Hematologic Malignancy Reports is 13. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions99
Monoclonal Gammopathy-Associated Neuropathy28
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations27
Management of Chronic Myeloid Leukemia in Children and Young Adults24
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease19
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications17
Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities17
Treatment-Free Remission: the New Goal in CML Therapy16
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations16
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer14
Value in Myeloma Care: Myth or Reality14
Challenges in Chronic Myeloid Leukemia Management in South America13
Transplantation and Cellular Therapy for Older Adults—The MSK Approach13
Targeting Apoptosis in ALL13
0.029104948043823